X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE FRESENIUS KABI ONCO. TTK HEALTHCARE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 28.4 22.1 128.2% View Chart
P/BV x 5.2 3.1 167.8% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 TTK HEALTHCARE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
FRESENIUS KABI ONCO.
Mar-13
TTK HEALTHCARE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs663176 376.9%   
Low Rs39979 508.3%   
Sales per share (Unadj.) Rs535.637.7 1,421.3%  
Earnings per share (Unadj.) Rs15.95.1 313.1%  
Cash flow per share (Unadj.) Rs20.06.7 297.9%  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.642.5 323.5%  
Shares outstanding (eoy) m7.77158.23 4.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.4 29.4%   
Avg P/E ratio x33.325.0 133.3%  
P/CF ratio (eoy) x26.518.9 140.1%  
Price / Book Value ratio x3.93.0 129.1%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,12720,135 20.5%   
No. of employees `0001.71.2 148.3%   
Total wages/salary Rs m607703 86.3%   
Avg. sales/employee Rs Th2,436.75,176.2 47.1%   
Avg. wages/employee Rs Th355.2610.4 58.2%   
Avg. net profit/employee Rs Th72.5699.6 10.4%   
INCOME DATA
Net Sales Rs m4,1625,963 69.8%  
Other income Rs m6118 340.0%   
Total revenues Rs m4,2235,981 70.6%   
Gross profit Rs m1971,430 13.8%  
Depreciation Rs m32258 12.3%   
Interest Rs m30-26 -115.0%   
Profit before tax Rs m1971,216 16.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-68 0.0%   
Tax Rs m73342 21.3%   
Profit after tax Rs m124806 15.4%  
Gross profit margin %4.724.0 19.7%  
Effective tax rate %37.028.1 131.5%   
Net profit margin %3.013.5 22.0%  
BALANCE SHEET DATA
Current assets Rs m1,6295,102 31.9%   
Current liabilities Rs m1,0582,385 44.3%   
Net working cap to sales %13.745.6 30.1%  
Current ratio x1.52.1 72.0%  
Inventory Days Days30150 19.8%  
Debtors Days Days34113 29.6%  
Net fixed assets Rs m5565,148 10.8%   
Share capital Rs m78158 49.1%   
"Free" reserves Rs m8786,556 13.4%   
Net worth Rs m1,0696,732 15.9%   
Long term debt Rs m159952 16.7%   
Total assets Rs m2,39910,388 23.1%  
Interest coverage x7.6-45.8 -16.6%   
Debt to equity ratio x0.10.1 104.9%  
Sales to assets ratio x1.70.6 302.2%   
Return on assets %6.47.5 85.4%  
Return on equity %11.612.0 96.8%  
Return on capital %18.514.6 126.4%  
Exports to sales %0.874.5 1.1%   
Imports to sales %1.424.8 5.7%   
Exports (fob) Rs m334,441 0.7%   
Imports (cif) Rs m581,477 3.9%   
Fx inflow Rs m335,298 0.6%   
Fx outflow Rs m631,772 3.6%   
Net fx Rs m-303,525 -0.9%   
CASH FLOW
From Operations Rs m1271,274 9.9%  
From Investments Rs m-146-1,204 12.1%  
From Financial Activity Rs m22-196 -11.2%  
Net Cashflow Rs m3-126 -2.0%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 3.7 0.3 1,233.3%  
FIIs % 5.2 9.6 54.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 9.1 283.5%  
Shareholders   12,723 42,599 29.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  WOCKHARDT LTD.  GSK PHARMA  PANACEA BIOTECH  

Compare TTK HEALTHCARE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 16, 2017 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS